⚪FOX04-DRI | 10mg
Product Details
Brand: MicroPharma.us
FOX04-DRI
| Unit Size | 10 mg/vial |
| Unit Quantity | 1 Vial |
| Sequence | D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-Gly-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-Gly-OH 11 AcOH |
| Appearance | White Powder |
| Peptide Purity | >98.1% |
| Solubility | Soluble in water or 1% acetic acid |
FOXO4-DRI is a peptide created for the purpose of scientific research, focusing on the interaction between FOXO4, a transcription factor, and p53, a protein known for its tumor-suppressing capabilities. The interaction between these two proteins plays a pivotal role in cellular senescence, a state in which cells cease to divide and accumulate over time, contributing to the aging process.
The design of FOXO4-DRI aims to interrupt the FOXO4-p53 interaction, thereby facilitating the study of its potential to trigger apoptosis in senescent cells. This research avenue is particularly intriguing within the scientific community, as it offers insights into the fundamental processes of cellular aging and holds promise for developing strategies to address age-related conditions in the future.
Please be aware that the information provided is based on scientific research and is for educational and informational purposes only. It is the subject of ongoing studies to further understand its potential and applications. Individuals should consult healthcare professionals before considering any peptide for therapeutic use.
OFFICIAL PARTNERS:
Display prices in:USD
